The first quantitative determination of melatonin utilized the effect of melatonin on dermal melano-
biological fluids has been developed. Melatonin antisera were raised in rabbits by immunization with bovine thyroglobulin conjugate of N-acetyl-5-methoxytryptophan. Two high-affinity and specific antisera were obtained. Unlike in previous studies melatonin was radioiodinated directly. Iodo-Gen was used as the oxidant. Radioiodinated melatonin was purified by TLC for use in RIA. Melatonin was extracted from plasma, serum and urine samples (1 ml) with chloroform. Using the extraction the sensitivity of the RIA method was 18 fmol/ml of original sample. Plasma, serum and urine extracts diluted parallelly with synthetic melatonin in RIA. HPLC analysis of plasma and serum extracts showed only one immunoreactive peak co-eluting with synthetic melatonin. Majority of urine immunoreactivity co-eluted with synthetic melatonin, but 7\p=n-\23% contaminating immunoreactivity was also observed. Daytime values for rat plasma, human serum and urine melatonin were 30\p=n-\60, 20\p=n-\40 and 50\p=n-\130 fmol/ml and the respective night values were 160\p=n-\300, 180\p=n-\370 and 230\p=n-\470 fmol/ml. (Fig. 2) . In HPLC studies the immunoreactive melatonin in plasma, serum and urine extracts (Fig. 3 ) co-eluted with synthetic melatonin. In HPLC profile of human urine extracts a minor peak eluting before melatonin was detectable (Fig. 3C) . This corresponded to 7-23% of total immunoreactivity. In rat plasma, human serum and human urine melatonin concentrations were higher during the scotophase than during the photophase (Fig. 4) . Urinary excretion of melato¬ nin has the same diurnal rhythm: 3-9 pmol/h in the photophase and 11-28 pmol/h in the scoto¬ phase. Intra-and inter-assay coefficients of varia¬ tion were 6.7-9.5 and 9.8-12.5%, respectively, at the dose level 110-440 pmol/1. Non-specific bind¬ ing was 7-9%. 
